YouTube Facebook LinkedIn Google+ Twitter Xingrss  

GSK Invests in Drug Discovery Startups


April 23, 2013 | GlaxoSmithKline is providing as much as $465 million in startup funds for Avalon Ventures to invest in drug-discovery companies over the next three years. Avalon will invest $30 million of their own funds as well. Xconomy
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact  Jay Mulhern, (781) 972-1359, jmulhern@healthtech.com.